NCT06980363

Brief Summary

  • For both groups, local anaesthesia will be administered by one single surgeon and the extraction will be performed by another single surgeon across all subjects. The surgeon performing the extraction will be blinded with regard to the local anaesthesia technique used in this study
  • A buccal infiltration injection of 1.5 ml of 4% articaine with 1:100,000 adrenaline (Septocaine, Septodont, New Castle, Del.) plus 1.5 ml of hyaluronidase enzyme (7.5IU/1ml) will be used in the study group while use 4% articaine with 1:100,000 adrenaline (Septocaine, Septodont, New Castle, Del.)only in traditional inferior alveolar nerve block in the control group
  • In study and control groups, VAS (visual analogue scale=is an unmarked, continuous, horizontal,100-mm line, anchored by the end points of "no pain" on the left and "worst pain" on the right ) will be used to evaluate the pain levels of the patients associated with the injection and during extraction

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jun 2025

Shorter than P25 for phase_1

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 27, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

May 7, 2025

Last Update Submit

May 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • visual analogue scale (VAS)0_10

    Ask the patient to scoring his pain during the extraction by visualanalogue scale0\_10 as 0 no pain and 10 sever pain

    Periprocedural

Study Arms (2)

traditional inferior alveolar nerve block by articaine

ACTIVE COMPARATOR
Drug: traditional inferior alveolar nerve block by articaine

hyaluronidase plus articain buccal infiltration

EXPERIMENTAL
Drug: hyaluronidase plus articain buccal infilteration

Interventions

use articaine for inferior alveolar nerve block with buccal infiltration to anesthetized lower molar teeth

traditional inferior alveolar nerve block by articaine

use of articain plus hyaluronidase enzyme buccal infiltration to anesthetized lower molar teeth

hyaluronidase plus articain buccal infiltration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medically stable patients
  • Seeking for non surgical extraction of mandibular molar tooth

You may not qualify if:

  • history of metabolic or systemic diseases affecting bone or healing process,
  • local infection
  • Grade III mobility
  • Neurological disorder
  • an analgesic use within 24 hours before anaesthesia administration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Hyaluronoglucosaminidase

Intervention Hierarchy (Ancestors)

Glycoside HydrolasesHydrolasesEnzymesEnzymes and CoenzymesPolysaccharide-LyasesCarbon-Oxygen LyasesLyases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 20, 2025

Study Start

June 1, 2025

Primary Completion

August 1, 2025

Study Completion

August 27, 2025

Last Updated

May 20, 2025

Record last verified: 2025-05